Difference between revisions of "Haloperidol LA"
From Psychiatrienet
Line 18: | Line 18: | ||
| halflife_ref = <ref name="pts">{{pts|3791}}</ref> | | halflife_ref = <ref name="pts">{{pts|3791}}</ref> | ||
| administration = IM | | administration = IM | ||
− | | DDD = | + | | DDD = 3.3 |
| DDD_ref = <ref>{{WHOCC|N05AD01}}</ref> | | DDD_ref = <ref>{{WHOCC|N05AD01}}</ref> | ||
| ctox = 20 | | ctox = 20 |
Revision as of 19:05, 23 April 2010
Haloperidol long acting | |||||||||||||||
Type | Antipsychotic | ||||||||||||||
Group | Butyrophenones | ||||||||||||||
links | |||||||||||||||
ATC-code | N05AD01 | ||||||||||||||
Medscape | Haloperidol | ||||||||||||||
PubChem | 3559 | ||||||||||||||
PubMed | Haloperidol | ||||||||||||||
Drugs.com | haloperidol | ||||||||||||||
Kompas (Dutch) | Haloperidol | ||||||||||||||
Wikipedia | Haloperidol | ||||||||||||||
|
Haloperidol (long acting) is a Antipsychotic in the group Butyrophenones.